1887

Abstract

Many genes in the ergosterol biosynthetic pathway are controlled by the transcriptional activator Upc2p, which is upregulated in the presence of azole drugs and has been suggested to regulate its own transcription by an autoregulatory mechanism. The promoter was cloned upstream of a luciferase reporter gene (). activity was induced in response to ergosterol biosynthesis inhibitors and in response to anaerobicity. Under both conditions, induction correlates with the magnitude of sterol depletion. Azole inducibility in the parental strain was approximately 100-fold, and in a homozygous deletion strain was 17-fold, suggesting that, in addition to autoregulation, transcription is controlled by a novel, Upc2p-independent mechanism(s). Curiously, basal activity was fivefold higher in the deletion strain, which may be an indirect consequence of the lower sterol level in this strain, or a direct consequence of repression by an autoregulatory mechanism. These results suggest that transcriptional regulation of expression is important in the response to antifungal drugs, and that this regulation occurs through Upc2p-dependent as well as novel Upc2p-independent mechanisms.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.2008/017475-0
2008-09-01
2019-12-08
Loading full text...

Full text loading...

/deliver/fulltext/micro/154/9/2748.html?itemId=/content/journal/micro/10.1099/mic.0.2008/017475-0&mimeType=html&fmt=ahah

References

  1. Abramova, N. E., Cohen, B. D., Sertil, O., Kapoor, R., Davies, K. J. & Lowry, C. V. ( 2001; ). Regulatory mechanisms controlling expression of the DAN/TIR mannoprotein genes during anaerobic remodeling of the cell wall in Saccharomyces cerevisiae. Genetics 157, 1169–1177.
    [Google Scholar]
  2. Arthington-Skaggs, B. A., Crowell, D. N., Yang, H., Sturley, S. L. & Bard, M. ( 1996; ). Positive and negative regulation of a sterol biosynthetic gene (ERG3) in the post-squalene portion of the yeast ergosterol pathway. FEBS Lett 392, 161–165.[CrossRef]
    [Google Scholar]
  3. Arthington-Skaggs, B. A., Jradi, H., Desai, T. & Morrison, C. J. ( 1999; ). Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37, 3332–3337.
    [Google Scholar]
  4. Davies, B. S., Wang, H. S. & Rine, J. ( 2005; ). Dual activators of the sterol biosynthetic pathway of Saccharomyces cerevisiae: similar activation/regulatory domains but different response mechanisms. Mol Cell Biol 25, 7375–7385.[CrossRef]
    [Google Scholar]
  5. Dimster-Denk, D. & Rine, J. ( 1996; ). Transcriptional regulation of a sterol-biosynthetic enzyme by sterol levels in Saccharomyces cerevisiae. Mol Cell Biol 16, 3981–3989.
    [Google Scholar]
  6. Henry, K. W., Nickels, J. T. & Edlind, T. D. ( 2000; ). Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44, 2693–2700.[CrossRef]
    [Google Scholar]
  7. Hoffman, C. S. & Winston, F. ( 1987; ). A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57, 267–272.[CrossRef]
    [Google Scholar]
  8. Hughes, A. L., Todd, B. L. & Espenshade, P. J. ( 2005; ). SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell 120, 831–842.[CrossRef]
    [Google Scholar]
  9. MacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M. & Turcotte, B. ( 2005; ). Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob Agents Chemother 49, 1745–1752.[CrossRef]
    [Google Scholar]
  10. Marie, C., Leyde, S. & White, T. C. ( 2008; ). Cytoplasmic localization of sterol transcription factors Upc2p and Ecm22p in S.cerevisiae. Fung Genet Biol (in press). http://dx.doi.org/10.1016/j.fgb.2008.07.004
    [Google Scholar]
  11. Oliver, B. G., Song, J. L., Choiniere, J. H. & White, T. C. ( 2007; ). cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through the transcription factor Upc2p. Eukaryot Cell 6, 2231–2239.[CrossRef]
    [Google Scholar]
  12. Pfaller, M. A. & Diekema, D. J. ( 2004; ). Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42, 4419–4431.[CrossRef]
    [Google Scholar]
  13. Reuss, O., Vik, A., Kolter, R. & Morschhauser, J. ( 2004; ). The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341, 119–127.[CrossRef]
    [Google Scholar]
  14. Sanglard, D., Ischer, F., Monod, M. & Bille, J. ( 1996; ). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40, 2300–2305.
    [Google Scholar]
  15. Setiadi, E. R., Doedt, T., Cottier, F., Noffz, C. & Ernst, J. F. ( 2006; ). Transcriptional response of Candida albicans to hypoxia: linkage of oxygen sensing and Efg1p-regulatory networks. J Mol Biol 361, 399–411.[CrossRef]
    [Google Scholar]
  16. Silver, P. M., Oliver, B. G. & White, T. C. ( 2004; ). Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell 3, 1391–1397.[CrossRef]
    [Google Scholar]
  17. Song, J. L., Harry, J. B., Eastman, R. T., Oliver, B. G. & White, T. C. ( 2004; ). The Candida albicans lanosterol 14-α-demethylase (ERG11) gene promoter is maximally induced after prolonged growth with antifungal drugs. Antimicrob Agents Chemother 48, 1136–1144.[CrossRef]
    [Google Scholar]
  18. Srikantha, T., Klapach, A., Lorenz, W. W., Tsai, L. K., Laughlin, L. A., Gorman, J. A. & Soll, D. R. ( 1996; ). The sea pansy Renilla reniformis luciferase serves as a sensitive bioluminescent reporter for differential gene expression in Candida albicans. J Bacteriol 178, 121–129.
    [Google Scholar]
  19. Vik, A. & Rine, J. ( 2001; ). Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae. Mol Cell Biol 21, 6395–6405.[CrossRef]
    [Google Scholar]
  20. White, T. C. & Silver, P. M. ( 2005; ). Regulation of sterol metabolism in Candida albicans by the UPC2 gene. Biochem Soc Trans 33, 1215–1218.[CrossRef]
    [Google Scholar]
  21. White, T. C., Marr, K. A. & Bowden, R. A. ( 1998; ). Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11, 382–402.
    [Google Scholar]
  22. Wilcox, L. J., Balderes, D. A., Wharton, B., Tinkelenberg, A. H., Rao, G. & Sturley, S. L. ( 2002; ). Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast. J Biol Chem 277, 32466–32472.[CrossRef]
    [Google Scholar]
  23. Znaidi, S., Weber, S., Al-Abdin, O. Z., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F. & Raymond, M. ( 2008; ). Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell 7, 836–847.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.2008/017475-0
Loading
/content/journal/micro/10.1099/mic.0.2008/017475-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error